Shuzhang Du

机构：Heilongjiang Academy of Sciences, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0002-0932-7099

发表论文 18 篇 · 总被引 168 次 · h-index 8

代表论文

• Autophagy upregulation promotes macrophages to escape mesoporous silica nanoparticle (MSN)-induced NF-κB-dependent inflammation (2016 · Inflammation Research · 被引 47)
• Docetaxel-loaded ultrasmall nanostructured lipid carriers for cancer therapy: in vitro and in vivo evaluation (2020 · Cancer Chemotherapy and Pharmacology · 被引 24)
• Palbociclib overcomes afatinib resistance in non-small cell lung cancer (2018 · Biomedicine & Pharmacotherapy · 被引 21)
• A Systematic Review of Health Economic Evaluation on Targeted Therapies for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Quality Evaluation (2020 · Cancer Management and Research · 被引 16)
• Ganoderma lucidum Polysaccharide Enhanced the Antitumor Effects of 5-Fluorouracil against Gastric Cancer through Its Upregulation of NKG2D/MICA (2019 · International Journal of Polymer Science · 被引 15)
• Cost-Effectiveness Analysis of PEG-rhG-CSF as Primary Prophylaxis to Chemotherapy-Induced Neutropenia in Women With Breast Cancer in China: Results Based on Real-World Data (2022 · Frontiers in Pharmacology · 被引 13)